AMESBURY – Cider Hill Farm is preparing to host a number of blood drives in the coming months, inspired by the story of their ...

The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), ...

Bristol Myers’ (BMY) is striving hard for the label expansion of its key drugs. The company’s growth portfolio comprises ...

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.

SAN DIEGO — Genetic mutations related to myelodysplastic syndrome occurred significantly more often among people who smoked than nonsmokers, according to study results presented at ASH ...

If you have myelodysplastic syndromes (MDS), your doctor may take a "watch and wait” approach, which may cause you anxiety and fear. These tips can help you cope.

Clinical trials for myelodysplastic syndromes (MDS) may offer a way to explore emerging treatments since traditional therapies may not work for everyone.

In Myelodysplastic Syndromes, Does Survival Differ in Black and White Patients? —In this study, Black individuals were found to have better overall survival from myelodysplastic syndromes than ...

Hetty Carraway, MD, illustrates the role of allogenic stem cell transplant in MDS and the criteria used to determine a patient’s eligibility.

A panel of experts open a discussion on the expanding awareness of myelodysplastic syndromes (MDS).

Novel treatment options in lower- and higher-risk patients with myelodysplastic syndromes and a promising targeted therapy are among MDS highlights from ASCO 2022, as discussed by Dr Amy DeZern.